Menu
GeneBe

1-48663230-C-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The NM_032785.4(AGBL4):c.646G>A(p.Glu216Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,613,894 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00062 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 2 hom. )

Consequence

AGBL4
NM_032785.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.12
Variant links:
Genes affected
AGBL4 (HGNC:25892): (AGBL carboxypeptidase 4) Predicted to enable metallocarboxypeptidase activity and tubulin binding activity. Predicted to be involved in C-terminal protein deglutamylation; defense response to virus; and protein side chain deglutamylation. Predicted to act upstream of or within several processes, including axonal transport of mitochondrion; positive regulation of ubiquitin-dependent protein catabolic process; and regulation of blastocyst development. Located in Golgi apparatus; centriole; and ciliary basal body. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.057334572).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AGBL4NM_032785.4 linkuse as main transcriptc.646G>A p.Glu216Lys missense_variant 7/14 ENST00000371839.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AGBL4ENST00000371839.6 linkuse as main transcriptc.646G>A p.Glu216Lys missense_variant 7/142 NM_032785.4 P1Q5VU57-1
AGBL4ENST00000416121.5 linkuse as main transcriptc.184G>A p.Glu62Lys missense_variant 3/71
AGBL4ENST00000371838.5 linkuse as main transcriptc.646G>A p.Glu216Lys missense_variant 7/95

Frequencies

GnomAD3 genomes
AF:
0.000624
AC:
95
AN:
152126
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00101
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000425
AC:
106
AN:
249220
Hom.:
0
AF XY:
0.000481
AC XY:
65
AN XY:
135198
show subpopulations
Gnomad AFR exome
AF:
0.000258
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000464
Gnomad NFE exome
AF:
0.000868
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.00118
AC:
1720
AN:
1461650
Hom.:
2
Cov.:
30
AF XY:
0.00111
AC XY:
806
AN XY:
727106
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000375
Gnomad4 NFE exome
AF:
0.00147
Gnomad4 OTH exome
AF:
0.00114
GnomAD4 genome
AF:
0.000624
AC:
95
AN:
152244
Hom.:
0
Cov.:
32
AF XY:
0.000497
AC XY:
37
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.000289
Gnomad4 AMR
AF:
0.000654
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00101
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000898
Hom.:
1
Bravo
AF:
0.000718
ExAC
AF:
0.000364
AC:
44
EpiCase
AF:
0.000982
EpiControl
AF:
0.000948

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 16, 2021The c.646G>A (p.E216K) alteration is located in exon 7 (coding exon 7) of the AGBL4 gene. This alteration results from a G to A substitution at nucleotide position 646, causing the glutamic acid (E) at amino acid position 216 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.52
Cadd
Benign
19
Dann
Uncertain
0.99
DEOGEN2
Benign
0.0042
T;.;.
Eigen
Benign
0.037
Eigen_PC
Benign
0.20
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.81
T;T;T
M_CAP
Benign
0.0076
T
MetaRNN
Benign
0.057
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L;.;.
MutationTaster
Benign
0.63
D;D;D
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.22
N;.;N
REVEL
Benign
0.059
Sift
Benign
0.61
T;.;T
Sift4G
Benign
0.69
T;T;T
Polyphen
0.25
B;.;.
Vest4
0.19
MVP
0.10
MPC
0.19
ClinPred
0.040
T
GERP RS
4.7
Varity_R
0.046
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201991102; hg19: chr1-49128902; API